• 1
    Kobayashi T. A study on medical comorbidities in psychiatric patients in a provincial area. In: Kurosawa H (ed.). A Report on Psychiatric Emergency, Including Medical Comorbidities and Dementia (Research on Psychiatric and Neurological Diseases and Mental Health, H19-009). Japanese Government Publication 2008; 97126 (in Japanese).
  • 2
    Lyketsos CG, Dunn G, Kaminsky MJ, Breakey WR. Medical comorbidity in psychiatric inpatients: Relation to clinical outcomes and hospital length of stay. Psychosomatics 2002; 43: 2430.
  • 3
    Miller B, Paschall CB III, Svendsen DP. Mortality and medical comorbidity among patients with serious mental illness. Psychiatr. Serv. 2006; 57: 14821487.
  • 4
    Meloni D, Miccinesi G, Bencini A et al. Mortality among discharged psychiatric patients in Florence, Italy. Psychiatr. Serv. 2006; 57: 14741481.
  • 5
    Key SR, Opler LA, Fiszbein A. Positive and Negative Syndrome Scale (PANSS) Rating Manual. Multi-Health System Inc., Toronto, 1991.
  • 6
    Breier A, Meehan K, Birkett M et al. A double-blind, placebo-controlled dose–response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia. Arch. Gen. Psychiatry 2002; 59: 441448.
  • 7
    Felker B, Yazel JJ, Short D. Mortality and medical comorbidity among psychiatric patients: A review. Psychiatr. Serv. 1996; 47: 13561363.
  • 8
    Goldman LS. Comorbid medical illness in psychiatric patients. Curr. Psychiatry Rep. 2000; 2: 256263.
  • 9
    Hatta K, Kurosawa H, Arai H. Hospitalization for medical comorbidities among psychiatric patients in Tokyo. Psychiatr. Serv. 2007; 58: 1502.
  • 10
    Hatta K, Takahashi T, Nakamura H et al. Abnormal physiological conditions in acute schizophrenic patients on emergency admission: Dehydration, hypokalemia, leukocytosis and elevated serum muscle enzymes. Eur. Arch. Psychiatry Clin. Neurosci. 1998; 248: 180188.